HyOrc Corporation filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 20, 2026, covering the quarterly period ended September 30, 2026.

Key Highlights

  • Net loss for the nine months ended September 30, 2026: $(1,672,896), compared to $(142,309) for the same period in 2025, according to the filing.
  • Third-quarter net loss: $(898,524) for the three months ended September 30, 2026, versus $(59,829) for the same quarter in 2025.
  • Total assets: $21,953,016 as of September 30, 2026, up from $21,735,860 at December 31, 2025.
  • Derivative liability and convertible notes: The balance sheet reflects a derivative liability of $724,850 and convertible notes payable, net of discount, of $229,415 as of September 30, 2026, both of which were $0 at December 31, 2025.
  • Shares outstanding: As of November 6, 2026, the registrant reported 760,035,299 shares of common stock outstanding.
  • Revenue: The company reported $24,000 in revenue for the nine months ended September 30, 2026, compared to $150 for the same period in 2025; revenue was $0 for the three months ended September 30, 2026.
  • Total stockholders' equity: $20,902,344 as of September 30, 2026, down from $21,720,860 at December 31, 2025.

HyOrc Corporation Q3 2026 Financial Results and Balance Sheet Changes

HyOrc Corporation, a Wyoming-incorporated company headquartered in Houston, Texas, disclosed its unaudited consolidated financial results for the nine months ended September 30, 2026, in a Form 10-Q filed November 20, 2026. The filing shows the company had no revenue in the third quarter of 2026, with nine-month revenue of $24,000 compared to $150 for the first nine months of 2025. Total expenses for the nine months ended September 30, 2026, reached $1,696,896, against $158,018 in the comparable prior-year period, according to the filing.

The filing identifies several new expense categories not present in the prior-year period. These include interest expense of $232,141, loan issuance costs of $16,030, a loss on issuance of convertible notes and commitment shares of $296,037, equity line commitment costs of $46,000, and a loss on extinguishment of debt of $136,531, all for the nine months ended September 30, 2026. Administrative and other expenses also increased to $943,550 for the nine-month period, compared to $158,018 in the same period of 2025. The company reported that the accumulated deficit grew to $(10,440,431) as of September 30, 2026, from $(8,767,535) at December 31, 2025.

On the balance sheet, the filing shows the company's current liabilities rose to $1,050,672 at September 30, 2026, from $15,000 at December 31, 2025. New liabilities include a derivative liability of $724,850, convertible notes payable net of discount of $229,415, accrued interest payable of $17,726, accrued compensation of $60,000, and a subscription money advance of $12,970. Plant and equipment, net, stood at $2,323,252, and construction in progress was recorded at $170,000, up from $0 at year-end 2025. The company had cash and cash equivalents of $63,321 as of September 30, 2026. The securities registered under Section 12(b) table lists "None" with no exchange and no trading symbol.

What Was Disclosed

HyOrc Corporation disclosed its unaudited financial statements for Q3 2026, reporting a nine-month net loss of $(1,672,896), new convertible debt and derivative liabilities, minimal revenue, and an accumulated deficit of $(10,440,431) as of September 30, 2026.